 | Up a level |
Journal Article
Cuppens, Tine, Annibali, Daniela 
ORCID: 0000-0001-8413-7669, Coosemans, An ORCID: 0000-0002-7321-4339, Trovik, Jone, ter Haar, Natalja, Colas, Eva, Garcia-Jimenez, Angel ORCID: 0000-0002-7635-3174, Van de Vijver, Koen ORCID: 0000-0002-2026-9790, Kruitwagen, Roy P. M., Brinkhuis, Mariel, Zikan, Michal ORCID: 0000-0001-5266-8895, Dundr, Pavel ORCID: 0000-0002-8940-6124, Huvila, Jutta, Carpen, Olli, Haybaeck, Johannes, Moinfar, Farid, Salvesen, Helga B., Stukan, Maciej ORCID: 0000-0003-2376-4663, Mestdagh, Carole, Zweemer, Ronald P., Massuger, Leonardus F., Mallmann, Michael R., Wardelmann, Eva, Mints, Miriam, Verbist, Godelieve, Thomas, Debby ORCID: 0000-0003-3075-9846, Gomme, Ellen, Hermans, Els, Moerman, Philippe, Bosse, Tjalling and Amant, Frederic ORCID: 0000-0002-5452-4905
(2017).
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
Clin. Cancer Res., 23 (5).
S. 1274 - 1286.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265